Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| B cell | 18 studies | 22% ± 4% | |
| non-classical monocyte | 18 studies | 26% ± 10% | |
| memory B cell | 17 studies | 21% ± 4% | |
| naive B cell | 17 studies | 22% ± 5% | |
| macrophage | 16 studies | 24% ± 9% | |
| classical monocyte | 16 studies | 28% ± 11% | |
| fibroblast | 13 studies | 20% ± 5% | |
| monocyte | 12 studies | 23% ± 6% | |
| endothelial cell | 12 studies | 21% ± 6% | |
| ciliated cell | 10 studies | 25% ± 8% | |
| natural killer cell | 9 studies | 18% ± 3% | |
| basal cell | 9 studies | 27% ± 11% | |
| dendritic cell | 9 studies | 26% ± 13% | |
| CD16-positive, CD56-dim natural killer cell, human | 7 studies | 23% ± 6% | |
| epithelial cell | 7 studies | 32% ± 14% | |
| CD16-negative, CD56-bright natural killer cell, human | 6 studies | 19% ± 2% | |
| plasmacytoid dendritic cell | 6 studies | 22% ± 7% | |
| conventional dendritic cell | 5 studies | 32% ± 17% | |
| myeloid cell | 5 studies | 29% ± 5% | |
| abnormal cell | 5 studies | 25% ± 4% | |
| microglial cell | 5 studies | 25% ± 9% | |
| goblet cell | 5 studies | 22% ± 7% | |
| respiratory goblet cell | 4 studies | 29% ± 8% | |
| myofibroblast cell | 4 studies | 19% ± 3% | |
| immature B cell | 4 studies | 22% ± 3% | |
| mononuclear phagocyte | 4 studies | 21% ± 5% | |
| type I pneumocyte | 4 studies | 22% ± 2% | |
| gamma-delta T cell | 4 studies | 19% ± 6% | |
| ionocyte | 3 studies | 21% ± 6% | |
| secretory cell | 3 studies | 23% ± 6% | |
| lymphocyte | 3 studies | 20% ± 2% | |
| CD8-positive, alpha-beta T cell | 3 studies | 17% ± 1% | |
| type II pneumocyte | 3 studies | 24% ± 4% | |
| glutamatergic neuron | 3 studies | 23% ± 6% | |
| adventitial cell | 3 studies | 17% ± 1% | |
| pericyte | 3 studies | 19% ± 3% | |
| alveolar macrophage | 3 studies | 32% ± 10% | |
| mucosal invariant T cell | 3 studies | 17% ± 1% | |
| brush cell | 3 studies | 27% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 19141.38 | 1445 / 1445 | 100% | 108.24 | 183 / 183 |
| intestine | 100% | 20550.70 | 966 / 966 | 100% | 105.70 | 527 / 527 |
| lung | 100% | 20312.39 | 578 / 578 | 100% | 98.11 | 1155 / 1155 |
| ovary | 100% | 21266.36 | 180 / 180 | 100% | 83.26 | 430 / 430 |
| skin | 100% | 17809.67 | 1809 / 1809 | 100% | 98.35 | 472 / 472 |
| stomach | 100% | 14212.35 | 359 / 359 | 100% | 101.16 | 286 / 286 |
| kidney | 100% | 14266.34 | 89 / 89 | 100% | 118.64 | 900 / 901 |
| thymus | 100% | 14974.64 | 653 / 653 | 100% | 108.81 | 604 / 605 |
| prostate | 100% | 21057.00 | 245 / 245 | 100% | 89.25 | 500 / 502 |
| bladder | 100% | 21094.67 | 21 / 21 | 99% | 96.01 | 501 / 504 |
| breast | 100% | 16258.70 | 459 / 459 | 98% | 75.08 | 1100 / 1118 |
| uterus | 100% | 19971.12 | 170 / 170 | 97% | 87.40 | 445 / 459 |
| liver | 100% | 9522.21 | 226 / 226 | 96% | 53.57 | 391 / 406 |
| pancreas | 96% | 6325.17 | 315 / 328 | 97% | 98.36 | 172 / 178 |
| adrenal gland | 100% | 18059.14 | 258 / 258 | 92% | 57.21 | 211 / 230 |
| adipose | 100% | 17386.56 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 19079.98 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 126.22 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 154.90 | 29 / 29 |
| spleen | 100% | 26954.56 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 96.61 | 45 / 45 |
| peripheral blood | 100% | 24999.19 | 925 / 929 | 0% | 0 | 0 / 0 |
| heart | 95% | 6743.20 | 820 / 861 | 0% | 0 | 0 / 0 |
| brain | 32% | 1204.33 | 841 / 2642 | 37% | 9.53 | 263 / 705 |
| muscle | 21% | 859.38 | 169 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0019221 | Biological process | cytokine-mediated signaling pathway |
| GO_0043434 | Biological process | response to peptide hormone |
| GO_0033598 | Biological process | mammary gland epithelial cell proliferation |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0060397 | Biological process | growth hormone receptor signaling pathway via JAK-STAT |
| GO_0007165 | Biological process | signal transduction |
| GO_0048289 | Biological process | isotype switching to IgE isotypes |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0060443 | Biological process | mammary gland morphogenesis |
| GO_0002829 | Biological process | negative regulation of type 2 immune response |
| GO_0035771 | Biological process | interleukin-4-mediated signaling pathway |
| GO_0070666 | Biological process | regulation of mast cell proliferation |
| GO_0002296 | Biological process | T-helper 1 cell lineage commitment |
| GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
| GO_1902170 | Biological process | cellular response to reactive nitrogen species |
| GO_0048295 | Biological process | positive regulation of isotype switching to IgE isotypes |
| GO_0007259 | Biological process | cell surface receptor signaling pathway via JAK-STAT |
| GO_0042127 | Biological process | regulation of cell population proliferation |
| GO_0070301 | Biological process | cellular response to hydrogen peroxide |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0006952 | Biological process | defense response |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0019903 | Molecular function | protein phosphatase binding |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0001223 | Molecular function | transcription coactivator binding |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | STAT6 |
| Protein name | Signal transducer and activator of transcription 6 (IL-4 Stat) Signal transducer and activator of transcription Signal transducer and activator of transcription 6 |
| Synonyms | |
| Description | FUNCTION: Carries out a dual function: signal transduction and activation of transcription. Involved in IL4/interleukin-4- and IL3/interleukin-3-mediated signaling. . |
| Accessions | G3V568 A0A1W2PNW1 ENST00000555104.5 ENST00000557635.5 ENST00000640254.2 A0A494C0T4 H0YJH6 ENST00000554764.6 G3V5K5 P42226 G3V2H4 ENST00000554663.5 G3V370 ENST00000651176.1 ENST00000300134.8 [P42226-1] ENST00000555318.1 G3V2M3 G3V2L2 ENST00000553499.5 ENST00000553397.5 Q5FBW6 ENST00000537215.6 [P42226-3] ENST00000553275.1 ENST00000543873.6 [P42226-1] ENST00000454075.7 [P42226-1] ENST00000538913.6 [P42226-3] ENST00000556259.5 H0YIY2 ENST00000556155.5 [P42226-1] A0A510GIJ1 ENST00000555849.5 ENST00000553533.2 G3V5I8 |